Sale!

CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CDKN2B gene plays a crucial role in regulating cell division by controlling the cell cycle, thus acting as a tumor suppressor. Mutations or alterations in this gene can lead to various forms of cancer, including multiple endocrine neoplasia type 1 (MEN1). MEN1 is a rare hereditary condition characterized by the development of tumors in endocrine glands, such as the parathyroid, pituitary, and pancreas, which can be benign or malignant.

The CDKN2B-related genetic test is a specialized diagnostic tool designed to identify mutations in the CDKN2B gene that are associated with an increased risk of developing MEN1. This test is particularly important for individuals with a family history of MEN1 or related symptoms, as it can help in early diagnosis and management of the condition.

DNA Labs UAE offers the CDKN2B gene multiple endocrine neoplasia type 1 related genetic test. The test is conducted using advanced genetic sequencing techniques to ensure accuracy and reliability. The cost of the test is 4400 AED, which includes the analysis and interpretation of results by certified genetic counselors. By identifying individuals at risk, this test enables proactive monitoring and intervention, potentially reducing the impact of MEN1 on affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related Genetic Test

At DNA Labs UAE, we offer the CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related Genetic Test for individuals who may be at risk for developing tumors in multiple endocrine glands. This test utilizes NGS (Next-Generation Sequencing) technology to analyze the CDKN2B gene and identify any mutations or variations that may be associated with MEN1.

Test Details

The CDKN2B gene is responsible for regulating cell growth and division. Mutations in this gene can disrupt this process, leading to the development of tumors in the parathyroid glands, pancreas, and pituitary gland. Our NGS genetic testing allows for the simultaneous analysis of multiple genes, including CDKN2B, to accurately diagnose MEN1.

Components and Price

  • Test Name: CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related Genetic Test, it is important for the patient to provide their clinical history. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by MEN1.

Post Test Interpretation

Genetic testing for MEN1 and other inherited conditions should be performed by a qualified healthcare professional, such as a genetic counselor or medical geneticist. These professionals can provide appropriate pre- and post-test counseling and help interpret the results of the NGS genetic testing. It is also important to note that the specific genes included in the test may vary depending on the testing laboratory and the specific panel used.

Conclusion

The CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related Genetic Test offered at DNA Labs UAE is a valuable tool for diagnosing MEN1 and guiding appropriate management and treatment options for individuals and their families. By identifying mutations in the CDKN2B gene, this test allows for early detection and intervention, leading to improved outcomes for patients.

Test Name CDKN2B Gene Multiple endocrine neoplasia type 1 CDKN2B related Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CDKN2B Gene Multiple endocrine neoplasia type 1, CDKN2B related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDKN2B Gene Multiple endocrine neoplasia type 1, CDKN2B related NGS Genetic DNA Test gene CDKN2B
Test Details

The CDKN2B gene is associated with multiple endocrine neoplasia type 1 (MEN1), which is an inherited condition that predisposes individuals to develop tumors in multiple endocrine glands. MEN1 is characterized by the development of tumors in the parathyroid glands, pancreas, and pituitary gland.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the CDKN2B gene. This type of testing can identify mutations or variations in the CDKN2B gene that may be associated with MEN1.

The CDKN2B gene is involved in regulating cell growth and division, and mutations in this gene can disrupt this process, leading to the development of tumors. By identifying mutations in the CDKN2B gene, NGS genetic testing can help diagnose MEN1 and guide appropriate management and treatment options for individuals and their families.

It is important to note that NGS genetic testing for MEN1 may also include the analysis of other genes associated with the condition, such as the MEN1 gene itself. The specific genes included in the test may vary depending on the testing laboratory and the specific panel used.

Genetic testing for MEN1 and other inherited conditions should be performed by a qualified healthcare professional, such as a genetic counselor or medical geneticist, who can provide appropriate pre- and post-test counseling and help interpret the results.